Holt Capital Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $526K | Buy |
4,096
+1,096
| +37% | +$128K | 0.06% | 126 |
|
|
2026
Q1 | $361K | Buy |
3,000
+500
| +20% | +$57.7K | 0.05% | 135 |
|
|
2025
Q4 | $263K | Hold |
2,500
| – | – | 0.04% | 146 |
|
|
2025
Q3 | $210K | Sell |
2,500
-700
| -22% | -$57.7K | 0.03% | 146 |
|
|
2025
Q2 | $253K | Hold |
3,200
| – | – | 0.04% | 139 |
|
|
2025
Q1 | $287K | Sell |
3,200
-1,950
| -38% | -$182K | 0.04% | 141 |
|
|
2024
Q4 | $512K | Sell |
5,150
-18
| -0.3% | -$1.86K | 0.08% | 120 |
|
|
2024
Q3 | $587K | Buy |
5,168
+918
| +22% | +$109K | 0.09% | 113 |
|
|
2024
Q2 | $526K | Sell |
4,250
-53
| -1% | -$6.83K | 0.11% | 102 |
|
|
2024
Q1 | $568K | Buy |
4,303
+53
| +1% | +$6.53K | 0.09% | 116 |
|
|
2023
Q4 | $463K | Buy |
4,250
+25
| +0.6% | +$2.6K | 0.08% | 118 |
|
|
2023
Q3 | $435K | Hold |
4,225
| – | – | 0.09% | 115 |
|
|
2023
Q2 | $488K | Buy |
4,225
+1,725
| +69% | +$196K | 0.09% | 114 |
|
|
2023
Q1 | $266K | Sell |
2,500
-500
| -17% | -$54K | 0.05% | 140 |
|
|
2022
Q4 | $333K | Hold |
3,000
| – | – | 0.07% | 127 |
|
|
2022
Q3 | $258K | Hold |
3,000
| – | – | 0.08% | 123 |
|
|
2022
Q2 | $274K | Hold |
3,000
| – | – | 0.06% | 137 |
|
|
2022
Q1 | $246K | Hold |
3,000
| – | – | 0.04% | 148 |
|
|
2021
Q4 | $230K | Hold |
3,000
| – | – | 0.04% | 159 |
|
|
2021
Q3 | $225K | Hold |
3,000
| – | – | 0.04% | 152 |
|
|
2021
Q2 | $233K | Sell |
3,000
-144
| -5% | -$10.7K | 0.04% | 150 |
|
|
2021
Q1 | $231K | Buy |
+3,144
| New | +$232K | 0.05% | 147 |
|
|
2020
Q3 | – | Sell |
-2,777
| Closed | -$205K | – | 150 |
|
|
2020
Q2 | $205K | Buy |
+2,777
| New | +$209K | 0.06% | 134 |
|
|
2016
Q2 | – | Sell |
-1,991
| Closed | -$101K | – | 166 |
|
|
2016
Q1 | $101K | Buy |
+1,991
| New | +$97.5K | 0.04% | 148 |
|
|
2015
Q4 | – | Sell |
-1,991
| Closed | -$94K | – | 162 |
|
|
2015
Q3 | $94K | Hold |
1,991
| – | – | 0.04% | 139 |
|
|
2015
Q2 | $108K | Hold |
1,991
| – | – | 0.04% | 138 |
|
|
2015
Q1 | $109K | Hold |
1,991
| – | – | 0.04% | 136 |
|
|
2014
Q4 | $108K | Buy |
+1,991
| New | +$111K | 0.05% | 137 |
|
|
2014
Q3 | – | Sell |
-1,991
| Closed | -$110K | – | 155 |
|
|
2014
Q2 | $110K | Hold |
1,991
| – | – | 0.06% | 97 |
|
|
2014
Q1 | $108K | Hold |
1,991
| – | – | 0.06% | 96 |
|
|
2013
Q4 | $95K | Buy |
+1,991
| New | +$91K | 0.06% | 102 |
|
Other funds holding MRK
Holt Capital Partners's MRK Position: Q2 2026 in Review
Holt Capital Partners increased its Merck (MRK) stake by 37% in Q2 2026, buying an estimated $128K and bringing the position to 4,096 shares worth $526K. The position accounts for 0.06% of the portfolio, ranked #126.
Holt Capital Partners first reported a position in MRK in Q4 2013 and has held it in 31 quarters since. The position peaked at $587K in Q3 2024. 3,829 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Holt Capital Partners held 4,096 shares of Merck worth $526K as of Q2 2026.
- Holt Capital Partners bought 1,096 Merck shares in Q2 2026, an estimated $128K.
- Merck made up 0.06% of Holt Capital Partners's portfolio in Q2 2026, its #126 holding.
- Holt Capital Partners first reported a position in Merck in Q4 2013 and has held it in 31 quarters since.
- Holt Capital Partners's Merck position peaked at $587K in Q3 2024.
- 3,829 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Holt Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.